MAAT INDEX

CLAIM #37132 · Eli Lilly and Company (LLY) · 2026Q1 earnings call · Apr 30, 2026 · due Dec 31, 2027

That will be a gradual path in '26 as it starts and then continued growth in '27.

Ilya Yuffa · President of Lilly USA

PENDING
graded after results covering Dec 31, 2027 are reported

How to check this claim

Look at: Revenue or volume growth trajectory for the referenced product/business line, fiscal years 2026 and 2027

It came true if: 2026 growth positive but modest (gradual ramp) followed by 2027 growth rate higher than 2026's rate

Where: Company-disclosed segment/product revenue (10-K/10-Q, earnings release, or management commentary on quarterly calls)

Verify independently

SEC filings for LLY · Claim quote is verbatim from the 2026Q1 earnings call.